Genital Neoplasms, Female

• 

  Subject Areas on Research

  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. 
  • A Pilot Study of a Screening Program for Human Papillomavirus-Related Squamous Intraepithelial Lesion and Malignancy in Gynecologic Oncology Patients. 
  • A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. 
  • A quality improvement initiative to reduce venous thromboembolism on a gynecologic oncology service. 
  • A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. 
  • Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population. 
  • Adverse health outcomes in women exposed in utero to diethylstilbestrol. 
  • Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. 
  • Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. 
  • Association between endometriosis and gynecological cancers: a critical review of the literature. 
  • Association of Medicaid expansion with mortality from gynecologic cancers. 
  • Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists. 
  • Bcl10 is not a target for frequent mutation in human carcinomas. 
  • Biology and therapy with biologic agents in gynecologic cancer. 
  • COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation. 
  • Cancer in pregnancy: a review of the literature. Part I. 
  • Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer patients in the United States. 
  • Chemotherapy discontinuation processes in a gynecologic oncology population. 
  • Clinicopathologic study of 85 cases of melanoma of the female genitalia. 
  • Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. 
  • Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. 
  • Computed tomography-guided fine-needle aspiration of retroperitoneal lymph nodes in gynecologic oncology. 
  • Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies. 
  • Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies. 
  • Cost of care using prophylactic negative pressure wound vacuum on closed laparotomy incisions. 
  • Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. 
  • Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass. 
  • Defective release of vascular plasminogen activator in patients with gynecologic malignancies. 
  • Development of a Multi-Institutional Simulation-Based Gynecologic Brachytherapy Curriculum. 
  • Diversity and transparency in gynecologic oncology clinical trials. 
  • Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis: perspective derived from a clinicopathologic analysis of twenty-one cases. 
  • Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project. 
  • Effects of long-term estrogen replacement therapy. II. Neoplasia. 
  • Emergency department utilization by patients with gynecologic cancer in the United States. 
  • Emotions and social relationships for breast and gynecologic patients: a qualitative study of coping with recurrence. 
  • Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. 
  • European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies. 
  • Evaluation of a Preoperative Clinic for Women With Gynecologic Cancer. 
  • Family history of gynaecological cancers: relationships to the incidence of breast cancer prior to age 55. 
  • Gynecologic tumor markers. 
  • Health Services Research: Not just retrospective chart reviews. 
  • High-volume providers and brachytherapy practice: A Medicare provider utilization and payment analysis. 
  • Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy. 
  • Image-guided brachytherapy for gynecologic surgeons. 
  • Immunotherapy for gynaecological malignancies. 
  • Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis. 
  • Impact of a documentation intervention on health-assessment metrics on an inpatient gynecologic oncology service. 
  • Implementing guidelines for risk-stratified thromboprophylaxis among gynecologic oncology patients: A quality improvement initiative. 
  • Intensity-modulated radiation therapy in gynecologic malignancies. 
  • Intraoperative radiation therapy in the management of gynecologic and genitourinary malignancies. 
  • Intrathoracic metastasis from an extrathoracic malignancy: a radiographic approach to patient evaluation. 
  • Keratosis reduces sensitivity of anal cytology in detecting anal intraepithelial neoplasia. 
  • Label-Free Imaging of Female Genital Tract Melanocytic Lesions With Pump-Probe Microscopy: A Promising Diagnostic Tool. 
  • Limiting Access to Abortion Will Potentially Harm Patients With Gynecologic Cancers. 
  • Lymphoma of the female genital tract: current status. 
  • Magnetic resonance imaging of the female pelvis. 
  • Malignant melanoma of the mucous membranes: a review of 119 cases. 
  • Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database. 
  • Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research. 
  • Microarray analysis of gene expression in gynecologic cancers--still only the beginning. 
  • Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US. 
  • Novel Therapies in Gynecologic Cancer. 
  • Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. 
  • Oncology Nurse Navigation: Development and Implementation of a Program at a Comprehensive Cancer Center 
  • Origin, Incidence, and Management of Nongynecologic Pelvic Masses Seen on Cross-sectional Imaging. 
  • Palliative and hospice care in gynecologic cancer: a review. 
  • Palliative services enhance the quality and value of gynecologic cancer care. 
  • Pathology of colposcopic findings in 2635 diethylstilbestrol-exposed young women. 
  • Pathology of prenatal diethylstilbestrol exposure. 
  • Pelvic exenteration: factors associated with major surgical morbidity. 
  • Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgery. 
  • Place of death by region and urbanization among gynecologic cancer patients: 2006-2016. 
  • Postoperative survival and functional outcomes for patients with metastatic gynecological cancer to the spine: case series and review of the literature. 
  • Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression. 
  • Practical approach to MRI of female pelvic masses. 
  • Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies. 
  • Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers. 
  • Preoperative coagulation testing on a gynecologic oncology service. 
  • Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap? 
  • Prevention and early detection of cancer. 
  • Projecting the need for gynecologic oncologists for the next 40 years. 
  • Promoting timely goals of care conversations between gynecologic cancer patients at high-risk of death and their providers. 
  • Racial and ethnic disparities in palliative care utilization among gynecological cancer patients. 
  • Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial. 
  • Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity. 
  • Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery. 
  • Reducing non-surgical readmissions on a gynecologic oncology service. 
  • Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making. 
  • Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. 
  • Risk of Pelvic Fracture With Radiation Therapy in Older Patients. 
  • Risk of second primary cancers among survivors of gynecological cancers. 
  • Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer. 
  • Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. 
  • Role of stereotactic body radiotherapy in gynecologic radiation oncology. 
  • Scientific innovation--pathway to progress in women's cancer. 
  • Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD). 
  • Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall. 
  • Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery. 
  • Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: Intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy. 
  • Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. 
  • Society of Gynecologic Oncology (SGO) 2021 meeting report: Scaling new heights with innovative cancer care. 
  • Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models. 
  • Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. 
  • Summary of the 44th Annual Meeting on Women's Cancers. 
  • Synoptic reports in gynecologic pathology. 
  • Teenage acne and cancer risk in US women: A prospective cohort study. 
  • Test of mindfulness and hope components in a psychological intervention for women with cancer recurrence. 
  • The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. 
  • The Unique Issues With Brachytherapy in Low- and Middle-Income Countries. 
  • The effect of comorbid illness on receipt of cancer screening by older people. 
  • The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: a prospective longitudinal cohort study. 
  • The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. 
  • The p53 tumor suppressor gene frequently is altered in gynecologic cancers. 
  • The right question in the right database: epidural analgesia for gynecological oncologic surgery. 
  • The role of genetic testing for cancer susceptibility in gynecologic practice. 
  • The role of tumor markers in gynecologic oncology. 
  • The use of patient-reported outcome tools in Gynecologic Oncology research, clinical practice, and value-based care. 
  • The use of tumor markers in the management of patients with gynecologic carcinomas. 
  • To Fracture Not-Sustained Benefits of Intensity Modulated Radiation Therapy (IMRT) in Pelvic Malignancies. 
  • Treat-and-Release Emergency Department Utilization by Patients With Gynecologic Cancers. 
  • Tuboovarian abscess in postmenopausal women. 
  • Urinary diversion in the genitourinary cancer survivor. 
  • Usefulness of imaging-guided catheter drainage and talc sclerotherapy in patients with metastatic gynecologic malignancies and symptomatic pleural effusions. 
  • Vaginal adenosis in women born prior to the diethylstilbestrol era. 
  • Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies. 
  • We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. 
  • When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic. 
  • Work related stress among gynecologic oncologists. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Myers, Evan Robert, Walter L. Thomas Distinguished Professor of Obstetrics and Gynecology in the School of Medicine, Duke Cancer Institute